Marksans Pharma

quarterly
yearly
ParticularsDec '23Mar '24Jun '24Sep '24Dec '24
Revenue242.69237.39262.68339.99334.38
Expenses208.09198.99220.38263.65259.65
EBITDA43.3046.1049.4283.6382.45
EBIT34.8738.6342.5876.6275.02
Profit Before Tax34.6038.4042.3076.3374.72
Net Profit25.2932.9932.0263.2055.46
Financial Ratios
Operating Profit Margin17.94%20.47%19.42%27.10%26.44%
Net Profit Margin10.48%14.65%12.58%20.48%17.78%
Earning Per Share (Diluted)0.560.730.711.391.22
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2025 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.7.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ